查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1654676

全球血管攝影機市場 - 2025 至 2033 年

Global Angiography Machine Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 149 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024 年全球血管攝影機市場規模達到 113 億美元，預計到 2033 年將達到 190 億美元，2025-2033 年預測期內的複合年成長率為 6.0%。

血管攝影機是一種專門的醫學影像系統，用於即時顯示身體的血管、動脈和靜脈。它利用 X 光、CT 或 MRI 技術，通常與造影劑結合使用，來檢測阻塞、動脈瘤和血管畸形等異常情況。這台血管攝影機是現代醫學中重要的診斷和介入工具，可即時可視化血管，以診斷和治療各種心血管和神經系統疾病。其發展包括基於人工智慧的成像、混合系統和移動單元，提高了醫療診斷的可及性和準確性。

由於多種關鍵因素，包括心血管疾病發病率上升、技術進步以及微創手術的日益普及，對血管造影機的需求正在迅速成長。例如，根據美國疾病管制與預防中心的數據，每 33 秒就有一人死於心血管疾病。 2022 年，有 702,880 人死於心臟病。這相當於每5人死亡就有1人。隨著心血管疾病的增加，對用於診斷冠狀動脈疾病、周邊動脈疾病和其他血管問題的血管攝影機的需求激增。

市場動態：

促進因素與約束因素

科技進步日新月異

不斷進步的技術極大地推動了血管造影機市場的成長，預計將在預測期內推動市場的發展。這些創新正在提高診斷的準確性，最大限度地降低患者風險並提高效率，使血管造影機更容易獲得和更受歡迎。 3D 血管攝影徹底改變了血管的可視化方式。這些技術可以更好地可視化複雜的血管結構，這對於血管手術和支架植入尤其重要。

例如，2022 年 9 月，西門子醫療在印度推出了血管攝影系統 ARTIS icono。血管造影系統具有大大改進的2D和3D成像能力，從而提高了影像品質並降低了輻射需求。透過正弦旋轉，顱底和顱蓋可以以 3D 形式呈現，並且幾乎不會產生任何偽影，從而改善 C 臂的運動。 ARTIS icono Biplane 將協助中風中心應對治療更多患者、更快、更精確的綜合挑戰。

人工智慧 (AI) 演算法現已整合到血管造影系統中，以協助放射科醫生自動檢測血管阻塞、動脈瘤或狹窄等異常情況。例如，人工智慧技術被納入平板偵測器 (FPD) 血管造影系統，以提高影像清晰度和血管異常的自動偵測能力，減少人為錯誤並提高診斷準確性。

輻射暴露問題

雖然血管攝影仍然是血管疾病最有效的診斷和介入工具之一，但對輻射暴露的擔憂是限制其發展的重要因素。這些問題影響著患者和醫療保健專業人員，並影響血管造影機的採用和使用。

長期或反覆暴露於血管攝影儀的輻射會增加放射線誘發癌症、皮膚損傷和其他長期健康問題的風險。對於因冠狀動脈疾病 (CAD) 等慢性疾病而需要頻繁接受血管攝影檢查的患者來說，這尤其令人擔憂。

例如，接受冠狀動脈造影的患者隨著時間的推移會面臨累積高劑量輻射的風險，這可能導致癌症風險。 《美國心臟病學會雜誌》（JACC）發表的一項研究發現，重複進行心臟血管造影所造成的高累積輻射暴露可能使普通患者一生中患癌症的風險增加高達 1.4%。

隨著對輻射引起的健康風險的認知不斷增強，患者可能變得不願意接受血管造影手術，特別是在需要重複掃描或存在 CT 血管造影或 MRI 血管造影等替代成像方法的情況下。這可以減少某些醫療機構對血管攝影機的需求。

目錄

第1章：市場介紹和範圍

  • 報告目標
  • 報告範圍和定義
  • 報告範圍

第 2 章：高階主管見解與關鍵要點

  • 市場亮點和戰略要點
  • 主要趨勢和未來預測
  • 按產品類型分類
  • 技術片段
  • 按應用程式截取的程式碼片段
  • 最終用戶的程式碼片段
  • 按地區分類

第 3 章：動態

  • 影響因素
    • 驅動程式
      • 不斷進步的技術
    • 限制
      • 輻射暴露問題
    • 機會
    • 影響分析

第4章：戰略洞察與產業展望

  • 市場領導者和先驅者
    • 新興先鋒和傑出參與者
    • 擁有最大銷售品牌的成熟領導者
    • 擁有成熟產品的市場領導者
  • 新興創業公司和關鍵創新者
  • CXO 觀點
  • 最新進展與突破
  • 案例研究/正在進行的研究
  • 監管和報銷情況
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 波特五力分析
  • 供應鏈分析
  • 專利分析
  • SWOT 分析
  • 未滿足的需求和差距
  • 市場進入和擴張的推薦策略
  • 情境分析：最佳情況、基本情況和最壞情況預測
  • 定價分析和價格動態

第 5 章：血管攝影機市場（依產品類型）

  • X光血管攝影機
  • CT 血管攝影機
  • 磁振造影血管攝影機
  • 其他

第 6 章：血管造影機市場（依技術分類）

  • 2D血管攝影
  • 3D 血管攝影
  • 旋轉血管攝影
  • 其他

第 7 章：血管攝影機市場（按應用）

  • 冠狀動脈造影
  • 腦血管攝影
  • 肺血管攝影
  • 腎臟血管攝影
  • 腹部血管攝影
  • 肢體血管攝影

第 8 章：血管攝影機市場（依最終用戶分類）

  • 醫院
  • 專科診所
  • 診斷中心
  • 外科中心
  • 其他

第 9 章：血管造影機市場，按區域市場分析和成長機會

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 中東和非洲

第 10 章：競爭格局與市場定位

  • 競爭概況和主要市場參與者
  • 市佔率分析與定位矩陣
  • 策略夥伴關係、併購
  • 產品組合和創新的關鍵發展
  • 公司基準化分析

第 11 章：公司簡介

  • Siemens Healthineers AG
    • 公司概況
    • 產品組合和描述
    • 財務概覽
    • 關鍵進展
    • SWOT 分析
  • Canon Medical Systems ANZ Pty Limited.
  • GE HealthCare
  • Shimadzu Corporation
  • Koninklijke Philips NV
  • B. Braun SE

第 12 章：假設與研究方法

  • 資料收集方法
  • 數據三角測量
  • 預測技術
  • 數據驗證和確認

第 13 章：附錄

簡介目錄
Product Code: MD9110

The global angiography machine market reached US$ 11.3 billion in 2024 and is expected to reach US$ 19.0 billion by 2033, growing at a CAGR of 6.0% during the forecast period 2025-2033.

An angiography machine is a specialized medical imaging system used to visualize the blood vessels, arteries, and veins of the body in real time. It utilizes X-ray, CT, or MRI technology, often combined with a contrast agent, to detect abnormalities such as blockages, aneurysms and vascular malformations. This angiography machine is a critical diagnostic and interventional tool in modern medicine, enabling real-time visualization of blood vessels to diagnose and treat various cardiovascular and neurological conditions. Its evolution includes AI-based imaging, hybrid systems, and mobile units, improving accessibility and accuracy in medical diagnostics.

The demand for angiography machines is growing rapidly due to several key factors, including the rising prevalence of cardiovascular diseases, advancements in technology, and the increasing adoption of minimally invasive procedures. For instance, acording to the Centers for Disease Control and Prevention, one person dies every 33 seconds from cardiovascular disease. In 2022, 702,880 people died from heart disease. That's the equivalent of 1 in every 5 deaths. As the cardiovascular diseases increase, demand for angiography machines has surged to diagnose coronary artery disease, peripheral artery disease and other vascular issues.

Market Dynamics: Drivers & Restraints

Rising technological advancements

The rising technological advancements is significantly driving the growth of the angiography machine market and is expected to drive the market over the forecast period. These innovations are improving diagnostic accuracy, minimizing patient risk and enhancing efficiency, making angiography machines more accessible and desirable. 3D angiography have revolutionized the way blood vessels are visualized. These technologies allow for better visualization of complex vascular structures, which is especially important for vascular surgeries and stent placements.

For instance, in September 2022, Siemens Healthineers launched ARTIS icono, an angiography system, in India. The angiography system has much improved 2D and 3D imaging capabilities, which improve picture quality and reduce radiation requirements. The cranial base and skull cap may be portrayed in 3D with virtually no artifacts to improved C-arm movement with Sine Spin. ARTIS icono Biplane will assist stroke centers in meeting the combined challenge of treating more patients, faster, and with more precision.

Artificial Intelligence (AI) algorithms are now being integrated into angiography systems to assist radiologists in automatically detecting abnormalities such as blockages, aneurysms, or stenosis in blood vessels. For instance, AI technologies are being incorporated into flat-panel detector (FPD) angiography systems to enhance image clarity and automatic detection of vascular anomalies, reducing human error and improving diagnostic accuracy.

Radiation exposure concerns

While angiography remains one of the most effective diagnostic and interventional tools for vascular diseases, concerns over radiation exposure are a significant factor limiting its growth. These concerns affect both patients and healthcare professionals, influencing the adoption and utilization of angiography machines.

Prolonged or repeated exposure to radiation from angiography machines can increase the risk of radiation-induced cancers, skin damage and other long-term health issues. This is particularly concerning for patients who require frequent angiography procedures for chronic conditions like coronary artery disease (CAD).

For instance, patients undergoing coronary angiography are at risk of accumulating high doses of radiation over time, which can lead to cancer risks. A study published in JACC (Journal of the American College of Cardiology) found that high cumulative radiation exposure from repeated cardiac angiography could raise the lifetime risk of cancer by up to 1.4% for a typical patient.

As awareness about radiation-induced health risks grows, patients may become hesitant to undergo angiography procedures, especially in the case of repeated scans or when alternative imaging methods like CT angiography or MRI angiography exist. This can reduce the demand for angiography machines in certain healthcare settings.

Segment Analysis

The global angiography machine market is segmented based on product type, technology, application, end-user and region.

Application:

The coronary angiography segment is expected to dominate the angiography machine market share

Cardiovascular diseases are the leading cause of death worldwide, with coronary artery disease (CAD) being one of the most common types of heart disease. As the global population ages and lifestyle-related risk factors such as obesity, diabetes, and smoking increase, there is a corresponding rise in the demand for coronary angiography to detect and treat these conditions.

For instance, the World Health Organization (WHO) reports that cardiovascular diseases account for 32% of global deaths, with coronary artery disease (CAD) being a major contributor. This has led to a high demand for coronary angiography as the gold standard for diagnosing blockages and narrowing of coronary arteries.

Coronary angiography is considered the gold standard for diagnosing coronary artery disease (CAD), providing a clear view of the coronary arteries, allowing cardiologists to evaluate blockages, stenosis, and the need for interventional procedures. For instance, in North America and Europe, coronary angiography is widely used in cardiac catheterization labs (Cath Labs) for diagnosis and treatment planning of patients with chest pain, shortness of breath, or risk factors for CAD, making it the dominant use case for angiography systems in these regions.

Geographical Analysis

North America is expected to hold a significant position in the angiography machine market share

North America particularly the United States is a hub for innovation in medical imaging technologies, and this extends to the angiography market. Continuous advancements in 3D imaging, digital subtraction angiography, real-time image guidance and AI integration have positioned North America at the forefront of adopting next-generation angiography systems.

For instance, Philips Healthcare and GE Healthcare, two major players in the angiography market, have developed cutting-edge systems such as the Philips Azurion and GE Innova platforms, which offer superior imaging clarity and reduced radiation exposure. These advanced systems are widely used across North America in cardiology, vascular surgery, and interventional radiology.

North America leads the adoption of hybrid angiography systems that combine traditional angiography with CT, MRI, or 3D imaging to provide a more comprehensive diagnostic approach. These systems offer real-time imaging and guidance, making them particularly useful for minimally invasive procedures like angioplasty, stent placement, and neurovascular interventions.

For instance, the growing trend of hybrid operating rooms, particularly in U.S. hospitals, is a key factor driving the demand for advanced angiography machines. Hybrid ORs integrate angiography systems with CT/MRI imaging, providing the flexibility to perform complex procedures like cardiac bypass surgeries and endovascular aneurysm repairs in a single setting.

Asia-Pacific is growing at the fastest pace in the angiography machine market

Cardiovascular diseases are on the rise in Asia-Pacific due to aging populations, urbanization, and the growing prevalence of risk factors such as smoking, poor diet, and lack of physical activity. As a result, there is an increasing demand for angiography as a diagnostic tool to detect and treat conditions like coronary artery disease (CAD), stroke, and peripheral artery disease (PAD).

For instance, in China, heart disease is the leading cause of death, with a significant rise in coronary artery disease cases, prompting the need for advanced diagnostic tools like angiography. According to the World Health Organization (WHO), more than 4 million deaths in China are attributed to CVDs, leading to growing demand for angiography procedures.

Medical tourism in APAC is also contributing to the growth of the angiography machine market, as countries like India, Thailand, and Singapore attract patients from developed countries seeking affordable, high-quality medical care. Many international patients travel to APAC for heart surgeries, angioplasties, and angiography due to the region's cost-effectiveness and high-quality healthcare services.

For instance, India is a major medical tourism destination, especially for cardiac procedures. Hospitals in cities like New Delhi, Chennai, and Bangalore are equipped with state-of-the-art angiography systems to cater to both local and international patients.

Competitive Landscape

The major global players in the angiography machine market include Siemens Healthineers AG, Canon Medical Systems ANZ Pty Limited., GE HealthCare, Shimadzu Corporation, Koninklijke Philips N.V., B. Braun SE and among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global angiography machine market report delivers a detailed analysis with 58 key tables, more than 65 visually impactful figures, and 149 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Product Type
  • 2.4. Snippet by Technology
  • 2.5. Snippet by Application
  • 2.6. Snippet by End-User
  • 2.7. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Rising Technological Advancements
    • 3.1.2. Restraints
      • 3.1.2.1. Radiation Exposure Concerns
    • 3.1.3. Opportunity
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. Emerging Startups and Key Innovators
  • 4.3. CXO Perspectives
  • 4.4. Latest Developments and Breakthroughs
  • 4.5. Case Studies/Ongoing Research
  • 4.6. Regulatory and Reimbursement Landscape
    • 4.6.1. North America
    • 4.6.2. Europe
    • 4.6.3. Asia Pacific
    • 4.6.4. Latin America
    • 4.6.5. Middle East & Africa
  • 4.7. Porter's Five Force Analysis
  • 4.8. Supply Chain Analysis
  • 4.9. Patent Analysis
  • 4.10. SWOT Analysis
  • 4.11. Unmet Needs and Gaps
  • 4.12. Recommended Strategies for Market Entry and Expansion
  • 4.13. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.14. Pricing Analysis and Price Dynamics

5. Angiography Machine Market, By Product Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 5.1.2. Market Attractiveness Index, By Product Type
  • 5.2. X-ray Angiography Machines*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. CT Angiography Machines
  • 5.4. Magnetic Resonance Angiography Machines
  • 5.5. Others

6. Angiography Machine Market, By Technology

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 6.1.2. Market Attractiveness Index, By Technology
  • 6.2. 2D Angiography*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. 3D Angiography
  • 6.4. Rotational Angiography
  • 6.5. Others

7. Angiography Machine Market, By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Coronary Angiography*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Cerebral Angiography
  • 7.4. Pulmonary Angiography
  • 7.5. Renal Angiography
  • 7.6. Abdominal Angiography
  • 7.7. Extremity Angiography

8. Angiography Machine Market, By End-User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.1.2. Market Attractiveness Index, By End-User
  • 8.2. Hospitals*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Specialty Clinics
  • 8.4. Diagnostic Centers
  • 8.5. Surgical Centers
  • 8.6. Others

9. Angiography Machine Market, By Regional Market Analysis and Growth Opportunities

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.7.1. U.S.
      • 9.2.7.2. Canada
      • 9.2.7.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.7.1. Germany
      • 9.3.7.2. U.K.
      • 9.3.7.3. France
      • 9.3.7.4. Spain
      • 9.3.7.5. Italy
      • 9.3.7.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.7.1. Brazil
      • 9.4.7.2. Argentina
      • 9.4.7.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.7.1. China
      • 9.5.7.2. India
      • 9.5.7.3. Japan
      • 9.5.7.4. South Korea
      • 9.5.7.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape and Market Positioning

  • 10.1. Competitive Overview and Key Market Players
  • 10.2. Market Share Analysis and Positioning Matrix
  • 10.3. Strategic Partnerships, Mergers & Acquisitions
  • 10.4. Key Developments in Product Portfolios and Innovations
  • 10.5. Company Benchmarking

11. Company Profiles

  • 11.1. Siemens Healthineers AG*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Financial Overview
    • 11.1.4. Key Developments
    • 11.1.5. SWOT Analysis
  • 11.2. Canon Medical Systems ANZ Pty Limited.
  • 11.3. GE HealthCare
  • 11.4. Shimadzu Corporation
  • 11.5. Koninklijke Philips N.V.
  • 11.6. B. Braun SE

LIST NOT EXHAUSTIVE

12. Assumption and Research Methodology

  • 12.1. Data Collection Methods
  • 12.2. Data Triangulation
  • 12.3. Forecasting Techniques
  • 12.4. Data Verification and Validation

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us